Subacute thyroiditis during interferon-alpha therapy for chronic hepatitis C

被引:14
|
作者
Falaschi, P [1 ]
Martocchia, A [1 ]
DUrso, R [1 ]
Proietti, A [1 ]
机构
[1] UNIV NAPLES 2,CATTEDRA TERAPIA MED,NAPLES,ITALY
关键词
subacute thyroiditis; IFN-alpha; HCV; hepatitis;
D O I
10.1007/BF03347968
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 34-year-old woman with chronic hepatitis C received interferon-alpha (IFN-alpha) therapy. Her thyroid function was normal and thyroid autoantibodies were negative before treatment, Four months after the beginning of the therapy she presented a clinical course of thyroiditis with a transient thyrotoxicosis. The diagnosis of subacute thyroiditis was confirmed by laboratory, ultrasonography, radioiodine scanning and fine needle aspiration findings. Thyroid autoantibodies were persisting negative. She suspended IFN-alpha therapy and she started non steroidal anti-inflammatory agents and beta-blockers. Latent hypothyroidism subsequently developed, but L-thyroxine therapy resulted in a rapid normalization of thyroid function tests. (C) 1997, Editrice Kurtis.
引用
收藏
页码:24 / 28
页数:5
相关论文
共 50 条
  • [1] Subacute thyroiditis during interferon-alpha therapy for chronic hepatitis C
    Paolo Falaschi
    A. Martocchia
    R. D’Urso
    A. Proietti
    [J]. Journal of Endocrinological Investigation, 1997, 20 : 24 - 28
  • [2] Subacute thyroiditis induced by interferon-alpha therapy
    Stipho, S
    Hein, MD
    Feller, E
    Shah, SA
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S147 - S148
  • [3] Conception and pregnancy during interferon-alpha therapy for chronic hepatitis C
    Trotter, JF
    Zygmunt, AJ
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2001, 32 (01) : 76 - 78
  • [4] SUBACUTE THYROIDITIS ASSOCIATED WITH INTERFERON-ALPHA 2A THERAPY
    GONZALEZFERNANDEZ, B
    ARRANZ, A
    PENARRUBIA, MJ
    MARAZUELA, M
    [J]. HORMONE AND METABOLIC RESEARCH, 1995, 27 (01) : 45 - 46
  • [5] Subacute thyroiditis during interferon therapy for chronic hepatitis B infection
    Ömür, Ö
    Daglyöz, G
    Akarca, U
    Özcan, Z
    [J]. CLINICAL NUCLEAR MEDICINE, 2003, 28 (10) : 864 - 865
  • [6] Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection
    Willems, M
    Munte, K
    Vrolijk, JM
    Den Hollander, JC
    Böhm, M
    Kemmeren, MH
    De Man, RA
    Brouwer, JT
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (02) : 390 - 394
  • [7] Myxedema due to reversible thyroiditis induced by interferon-alpha 2a therapy for chronic hepatitis C
    Prignet, JM
    Duval, JL
    Raynard, B
    Louvety, S
    Kunkel, D
    [J]. SEMAINE DES HOPITAUX, 1996, 72 (11-12): : 353 - 356
  • [8] Systemic sarcoidosis during interferon-alpha therapy for chronic hepatitis C virus infection
    Cacoub, P
    Sbaï, A
    Francès, C
    Génesti, C
    Hausfater, P
    Piette, JC
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2000, 24 (03): : 364 - 366
  • [9] Acute autoimmune hemolytic anemia during interferon-alpha therapy for chronic hepatitis C
    Landau, A
    Castera, L
    Buffet, C
    Tertian, G
    Tchernia, G
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1999, 44 (07) : 1366 - 1367
  • [10] Ischemic colitis during pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C
    Leung, Yvette
    Urbanski, Stefan J.
    Schindel, Lynn
    Myers, Robert P.
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 20 (10) : 661 - 663